Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Non Operating Income of -$5.3 million for Q1 2026, down 888.61% on a YoY basis from $667000.0 in Q1 2025, and up 80.88% sequentially from -$27.5 million in Q4 2025.
Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Non Operating Income data on file, last reported at -$5.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 888.61% year-over-year to -$5.3 million; the trailing twelve-month figure through Mar 2026 stood at -$33.8 million (down 2293.18% YoY), and the FY2025 full-year result was -$27.8 million, down 2247.11% from the prior year.
- Non Operating Income improved to -$5.3 million in Q1 2026, from -$27.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $755000.0 in Q4 2024 to a low of -$27.5 million in Q4 2025.
- A 4-year average of -$2.8 million and a median of $423000.0 in 2024 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 412.79% in 2025, while the deepest fall reached 4625.0% in 2025.
- Tracing CAMP's Non Operating Income over 4 years: stood at $486000.0 in 2023, then surged by 55.35% to $755000.0 in 2024, then sank by 3743.44% to -$27.5 million in 2025, then soared by 80.88% to -$5.3 million in 2026.
- Business Quant data shows CAMP's Non Operating Income at -$5.3 million in Q1 2026, -$27.5 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -5.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.26 Mn |
| Dec 31, 2025 | -27.51 Mn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | 441,000.00 |
| Mar 31, 2025 | 667,000.00 |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 86,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | 486,000.00 |
| Sep 30, 2023 | 642,000.00 |